Click here - to use the wp menu builder
Search
Maverick Times
News with a
DIFFERENCE
Maverick Times
News with a
Difference
Go
Search
No menu items!
Category:
Defence news
Agency Copies
Banking News
Business news
Coronavirus
Crime news
Defence news
Entertainment news
This 14-year-old kid raised 665K to purchase oxygen concentrators in the fight against Covid19
Agency Copies
U.S. Food & Drug Administration Grants Priority Review of Maribavir for the Treatment of Post-Transplant Recipients With Cytomegalovirus Infection in Those Resistant and/or Refractory...
Agency Copies
Data from Merck’s Oncology Portfolio Highlight Significant Advances in Cancer Care at ASCO21
Defence news
BSF Detects the Tunnel used by the JeM terrorists for Infiltration in the Border area
Defence news
JeM terrorists killed in Nargota attack were planning big attack on 26/11 anniversary
Defence news
India in disagreement with China’s disengagement proposal in Pangong
Defence news
India dismissed the idea of shifting the LAC, China will pay said CDS
Defence news
New reforms to retain the Manpower in the armed forces, retirement age revised
Defence news
After cruise and land, aerial version of BrahMos missile successfully test-fired
Defence news
India acquires 11,000 Cold gear sets from US army
Defence news
NIA raids several locations supporting terrorist organisations in Srinagar and Bangalore
Defence news
Sri Lanka’s Navy attacks fishermen in Rameshwaram
Load more
This 14-year-old kid raised 665K to purchase oxygen concentrators in the fight against Covid19
May 23, 2021
U.S. Food & Drug Administration Grants Priority Review of Maribavir for the Treatment of Post-Transplant Recipients With Cytomegalovirus Infection in Those Resistant and/or Refractory...
May 22, 2021
Data from Merck’s Oncology Portfolio Highlight Significant Advances in Cancer Care at ASCO21
May 22, 2021
CHMP issues positive opinion for Jardiance® (empagliflozin) for the treatment of adults with heart failure with reduced ejection fraction
May 22, 2021
Ferring and Rebiotix Present Landmark Phase 3 Data Demonstrating Superior Efficacy of Investigational RBX2660 Versus Placebo to Reduce Recurrence of C. difficile Infection
May 22, 2021